Complete Pathological Response to Crizotinib in a Patient with ALK-rearranged Lung Adenocarcinoma.
Overview
publication date
published in
Research
keywords
-
Adenocarcinoma of Lung
-
Anaplastic Lymphoma Kinase
-
Crizotinib
-
Gene Rearrangement
-
Lung Neoplasms
-
Protein Kinase Inhibitors
Identity
PubMed Central ID
Scopus Document Identifier
Digital Object Identifier (DOI)
-
10.1016/j.cllc.2019.10.002
PubMed ID
Additional Document Info
has global citation frequency
volume
issue